Condition: Sarcopenia · Total Knee Arthroplasty · Sponsor: Seoul National University Hospital
This multicenter, prospective, randomized controlled trial evaluates whether postoperative administration of branched chain amino acids affects skeletal muscle mass index and sarcopenia related functional outcomes in patients undergoing total knee arthroplasty. Participants are randomly assigned to receive Livact granules 4.15 g three times daily for 3 months after surgery or to receive standard postoperative care without branched chain amino acid administration. Skeletal muscle mass index, physical function, patient reported outcomes, laboratory findings, medication compliance, and adverse events are assessed at baseline, 5 weeks, and 15 weeks after surgery.
This description comes directly from the study's public registry record.
Hyunwoo Kim · +82-2-6072-5345 · hyunu0331@gmail.com
Always discuss trial participation with your own doctor first.
| CHA Bundang Medical Center | Seongnam-si, Gyeonggi-do, South Korea | Active Not Recruiting |
| Seoul National University Hospital | Seoul, Seoul, South Korea | Recruiting |
| Chung-Ang University Hospital | Seoul, Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07634523